Lennar Corporation LEN-B
Composite 43/100; the shares have moved about 38% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 12/100 — a strong mark against it.
Balance-sheet strength ranks 74/100 — a moderate point in its favour. Income ranks 66/100 — a moderate point in its favour. Valuation ranks 62/100 — a slight point in its favour.
Growth ranks 12/100 — a strong mark against it. Momentum ranks 16/100 — a strong mark against it. Quality ranks 33/100 — a moderate mark against it.
What the company does Lennar Corporation (LEN-B) is a U.S. homebuilder operating under the Lennar brand, constructing and selling single-family homes, multifamily rental properties, and providing mortgage financing and title services. Its segments include Homebuilding (East, Central, South Central, West), Financial Services, Multifamily, and Lennar Other. The company targets first-time, move-up, active adult, and luxury homebuyers.
Key financials Lennar’s trailing ROE is 7.4%, ROA 3.9%, and net margin 4.9%. Revenue declined -5.2% YoY, with EPS down -31.5%. Gross margin is 16.4%, operating margin 5.3%, and debt/equity is 0.29 with a current ratio of 8.51. The dividend yield is 2.5% with a 31.4% payout ratio.
Stock health Sideravia scores Lennar’s overall quality as 46.9 (poor), valuation 68.0 (attractive), and momentum 24.6 (weak). Profitability metrics like ROE and ROA are modest, while margins and liquidity remain healthy. Piotroski F-Score is 4/9, indicating mixed financial health.
Price vs fair value LEN trades at a PREMIUM of 0.50% to our fair-value estimate of 82.04. - Recent headlines flag Lennar as underperforming the broader market (Zacks, 2026-07-29). - Some analysts still view it as cheap based on earnings power (Simply Wall St., 2026-07-26). - Others exclude it from buy lists or rate it a strong sell (StockStory, Zacks, 2026-07-30/31).
Looking forward Forward P/E is 15.08, with valuation metrics like EV/EBITDA at 11.12 and P/B at 0.92. The stock’s weak momentum (RSI 46.60) contrasts with its attractive valuation percentile (68.0). Earnings expectations and sentiment remain mixed, with no consensus 12-month target provided.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.